×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| KOPRAN LTD. | 726.84 | 74.07 | 719.38 | 1.53 | 892.0 | 18.8 |
| Shukra Pharmaceuticals Limited | 115.91 | 31.64 | 105.84 | 0.72 | 848 | 104.0 |
| ANUH PHARMA LTD. | 1604.51 | 103.43 | 1595.13 | 2.06 | 819 | 16.3 |
Kopran Ltd.,, with Security Code 524280, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53.6 | 67.9 | 80.2 | 65.8 | 98.6 | 82.3 | 90.6 | 49.6 | 73.5 | 71.9 |
| Expenses | 47.7 | 61.9 | 72.9 | 63.7 | 89.9 | 70.3 | 75.3 | 44.3 | 63.8 | 60.5 |
| Operating Profit | 5.9 | 6.1 | 7.4 | 2.1 | 8.7 | 12.1 | 15.3 | 5.3 | 9.7 | 11.4 |
| OPM % | 11.01% | 8.98% | 9.18% | 3.23% | 8.82% | 14.65% | 16.93% | 10.65% | 13.18% | 15.85% |
| Other Income | 14.7 | 1.2 | 2.1 | 0.2 | 5.8 | 1.3 | 8.1 | 2.1 | 1.1 | 0.7 |
| Interest | 0.6 | 0.7 | 0.8 | 1.0 | 0.7 | 1.0 | 1.8 | 0.7 | 0.8 | 1.0 |
| Depreciation | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.3 |
| Profit before tax | 18.9 | 5.4 | 7.5 | 0.2 | 12.6 | 11.2 | 20.5 | 5.5 | 8.7 | 9.8 |
| Tax % | 5.4% | 25.4% | 26.5% | 32% | 15.3% | 23.7% | 25.5% | 23% | 24.5% | 24.6% |
| Net Profit | 17.9 | 4.0 | 5.5 | 0.2 | 10.7 | 8.5 | 15.3 | 4.2 | 6.6 | 7.4 |
| EPS in Rs | 3.71 | 0.84 | 1.14 | 0.03 | 2.2 | 1.76 | 3.17 | 0.87 | 1.37 | 1.53 |
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 125.6 | 117.0 | 158.0 | 148.9 | 117.0 | 152.6 | 158.9 | 186.1 | 139.4 | 151.6 |
| Expenses | 108.5 | 106.8 | 145.7 | 136.7 | 108.4 | 129.8 | 135.3 | 164.4 | 121.3 | 136.8 |
| Operating Profit | 17.1 | 10.1 | 12.3 | 12.2 | 8.6 | 22.8 | 23.6 | 21.7 | 18.2 | 14.7 |
| OPM % | 13.6% | 8.7% | 7.8% | 8.2% | 7.4% | 15% | 14.8% | 11.7% | 13% | 9.7% |
| Other Income | -3.3 | 0.4 | 2.2 | 3.8 | 0.1 | 0.1 | 2.4 | 9.7 | 2.6 | 1.0 |
| Interest | 0.8 | 1.3 | 2.2 | 1.8 | 1.8 | 1.9 | 2.2 | 2.6 | 2.2 | 2.2 |
| Depreciation | 3.1 | 3.3 | 3.2 | 3.2 | 3.3 | 2.8 | 3.3 | 3.6 | 3.9 | 3.9 |
| Profit before tax | 10.0 | 6.0 | 9.1 | 10.9 | 3.6 | 18.3 | 20.5 | 25.2 | 14.7 | 9.6 |
| Tax % | 23.7% | 23.1% | 24% | 26.4% | 23.2% | 24.6% | 23% | 26% | 24.7% | 23.4% |
| Net Profit | 7.6 | 4.7 | 6.9 | 8.0 | 2.8 | 13.8 | 15.8 | 18.6 | 11.1 | 7.4 |
| EPS in Rs | 1 | 0 | 1 | 1 | 0 | 2 | 3 | 3 | 2 | 1 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 11% |
| 3 Years: | 15% |
| TTM: | -13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 22% |
| 3 Years: | 14% |
| TTM: | 35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 45% |
| 3 Years: | -12% |
| 1 Year: | -30% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 16% |
| 3 Years: | -6% |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 45% |
| 3 Years: | -12% |
| 1 Year: | -30% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|